HRP20221402T1 - Kompleks gadolinija i kelirajućeg liganda dobivenog iz diastereoizomerno obogaćenog pcta te postupak pripreme i pročišćavanja - Google Patents

Kompleks gadolinija i kelirajućeg liganda dobivenog iz diastereoizomerno obogaćenog pcta te postupak pripreme i pročišćavanja Download PDF

Info

Publication number
HRP20221402T1
HRP20221402T1 HRP20221402TT HRP20221402T HRP20221402T1 HR P20221402 T1 HRP20221402 T1 HR P20221402T1 HR P20221402T T HRP20221402T T HR P20221402TT HR P20221402 T HRP20221402 T HR P20221402T HR P20221402 T1 HRP20221402 T1 HR P20221402T1
Authority
HR
Croatia
Prior art keywords
formula
complex
image
gadolinium
hexaacid
Prior art date
Application number
HRP20221402TT
Other languages
English (en)
Croatian (hr)
Inventor
Soizic Le Greneur
Alain CHÉNEDÉ
Martine Cerf
Myriam Petta
Emmanuelle MARAIS
Bruno François
Caroline ROBIC
Stéphanie LOUGUET
Original Assignee
Guerbet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guerbet filed Critical Guerbet
Publication of HRP20221402T1 publication Critical patent/HRP20221402T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HRP20221402TT 2019-01-17 2020-01-17 Kompleks gadolinija i kelirajućeg liganda dobivenog iz diastereoizomerno obogaćenog pcta te postupak pripreme i pročišćavanja HRP20221402T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1900432A FR3091873B1 (fr) 2019-01-17 2019-01-17 Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
PCT/EP2020/051153 WO2020148436A1 (fr) 2019-01-17 2020-01-17 Complexe de gadolinium et d'un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
EP20701709.6A EP3902800B1 (fr) 2019-01-17 2020-01-17 Complexe de gadolinium et d'un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification

Publications (1)

Publication Number Publication Date
HRP20221402T1 true HRP20221402T1 (hr) 2023-01-06

Family

ID=67001953

Family Applications (2)

Application Number Title Priority Date Filing Date
HRP20221402TT HRP20221402T1 (hr) 2019-01-17 2020-01-17 Kompleks gadolinija i kelirajućeg liganda dobivenog iz diastereoizomerno obogaćenog pcta te postupak pripreme i pročišćavanja
HRP20230678TT HRP20230678T1 (hr) 2019-01-17 2020-01-17 Kompleks gadolinija i kelirajućeg liganda izvedenog iz dijastereoizomerno obogaćenog pcta i postupak za njegovu pripremu i pročišćavanje

Family Applications After (1)

Application Number Title Priority Date Filing Date
HRP20230678TT HRP20230678T1 (hr) 2019-01-17 2020-01-17 Kompleks gadolinija i kelirajućeg liganda izvedenog iz dijastereoizomerno obogaćenog pcta i postupak za njegovu pripremu i pročišćavanje

Country Status (28)

Country Link
US (3) US11590246B2 (enExample)
EP (2) EP3902800B1 (enExample)
JP (2) JP7071596B2 (enExample)
KR (2) KR102438394B1 (enExample)
CN (3) CN113735854B (enExample)
AR (1) AR117835A1 (enExample)
AU (1) AU2020208794B2 (enExample)
BR (1) BR112021014006B1 (enExample)
CA (1) CA3126268C (enExample)
CL (1) CL2021001868A1 (enExample)
CO (1) CO2021009261A2 (enExample)
DK (2) DK3943493T3 (enExample)
ES (2) ES2930136T3 (enExample)
FI (1) FI3943493T3 (enExample)
FR (1) FR3091873B1 (enExample)
HR (2) HRP20221402T1 (enExample)
HU (2) HUE062554T2 (enExample)
IL (1) IL284884B2 (enExample)
MA (2) MA54626A (enExample)
MX (1) MX2021008651A (enExample)
PH (1) PH12021551725A1 (enExample)
PL (2) PL3902800T3 (enExample)
PT (2) PT3902800T (enExample)
RS (1) RS64334B1 (enExample)
SG (1) SG11202107779SA (enExample)
TW (1) TWI811518B (enExample)
WO (1) WO2020148436A1 (enExample)
ZA (1) ZA202104994B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10973934B2 (en) 2018-08-06 2021-04-13 Bracco Imaging S.P.A. Gadolinium bearing PCTA-based contrast agents
FR3091872B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese
FR3091873B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
US20230339945A1 (en) * 2020-07-17 2023-10-26 Guerbet Method for preparing a chelating ligand derived from pcta
WO2022072947A1 (en) * 2020-10-02 2022-04-07 Eagle Harbor Technologies, Inc. Ion current droop compensation
CN119698423A (zh) * 2022-09-01 2025-03-25 泰瑞诺科有限公司 新型化合物以及包含其的mri造影剂
KR102845061B1 (ko) * 2022-09-01 2025-08-13 주식회사 테라노큐어 신규한 화합물 및 이를 포함하는 mri 조영제
WO2026027591A1 (en) 2024-07-31 2026-02-05 Bracco Imaging Spa Synthesis of an intermediate of a gadolinium-based contrast agent

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3640708C2 (de) 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
DE4001655A1 (de) 1990-01-18 1991-07-25 Schering Ag 6-ring enthaltende makrocyclische tetraaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JPH04154729A (ja) 1990-10-16 1992-05-27 Nippon Mejifuijitsukusu Kk 磁気共鳴造影剤
IT1292128B1 (it) 1997-06-11 1999-01-25 Bracco Spa Processo per la preparazione di chelanti macrociclici e loro chelati con ioni metallici paramagnetici
EP0992245A1 (en) 1998-09-16 2000-04-12 Goldham Bioglan Pharma GmbH Radio-contrast agents
FR2793795B1 (fr) * 1999-05-21 2001-08-03 Guerbet Sa Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale
FR2794744B1 (fr) 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale
FR2891830B1 (fr) * 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
US20090208421A1 (en) * 2008-02-19 2009-08-20 Dominique Meyer Process for preparing a pharmaceutical formulation of contrast agents
US8119817B2 (en) * 2009-09-29 2012-02-21 Degussa-Huels Ag Process for separating the diastereomers of RSS-and SSS-N- α [1-carboxy-3-phenylpropyl] lysylproline
EP2786768A1 (en) * 2013-04-04 2014-10-08 Agfa Healthcare Process for preparing a material comprising a macrocyclic ligand and for producing a pharmaceutical formulation comprising said ligand with a lanthanide
CA2909919C (fr) * 2013-04-26 2022-07-12 Guerbet Formulation de produit de contraste et son procede de preparation associe
CN104188957B (zh) * 2014-05-28 2017-04-26 中国中医科学院西苑医院 一种防治再狭窄的药物及其制备和使用方法
SG11201909240SA (en) * 2017-04-28 2019-11-28 Otsuka Pharma Factory Inc Method for manufacturing diastereomer of citric acid derivative
US10973934B2 (en) * 2018-08-06 2021-04-13 Bracco Imaging S.P.A. Gadolinium bearing PCTA-based contrast agents
FR3091873B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
FR3091872B1 (fr) 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese

Also Published As

Publication number Publication date
CN113646308B (zh) 2024-12-13
HUE060343T2 (hu) 2023-02-28
ES2930136T3 (es) 2022-12-07
CA3126268A1 (fr) 2020-07-23
IL284884B2 (en) 2025-09-01
MX2021008651A (es) 2021-10-26
FI3943493T3 (fi) 2023-07-19
PT3943493T (pt) 2023-07-12
IL284884A (en) 2021-08-31
IL284884B1 (en) 2025-05-01
PL3902800T3 (pl) 2022-12-27
ZA202104994B (en) 2023-04-26
JP2022009463A (ja) 2022-01-14
MA55389A (fr) 2022-01-26
US12064487B2 (en) 2024-08-20
US20220062443A1 (en) 2022-03-03
PH12021551725A1 (en) 2022-04-11
EP3943493B1 (fr) 2023-04-19
CN113735854A (zh) 2021-12-03
SG11202107779SA (en) 2021-08-30
AR117835A1 (es) 2021-08-25
FR3091873A1 (fr) 2020-07-24
EP3902800A1 (fr) 2021-11-03
JP7321230B2 (ja) 2023-08-04
AU2020208794B2 (en) 2023-01-12
MA54626A (fr) 2022-04-20
TW202043227A (zh) 2020-12-01
US20230149568A1 (en) 2023-05-18
BR112021014006A2 (pt) 2021-09-21
PL3943493T3 (pl) 2023-08-07
WO2020148436A1 (fr) 2020-07-23
CO2021009261A2 (es) 2021-12-10
BR112021014006B1 (pt) 2023-05-02
CN113646308A (zh) 2021-11-12
TWI811518B (zh) 2023-08-11
JP7071596B2 (ja) 2022-05-19
RS64334B1 (sr) 2023-08-31
CA3126268C (fr) 2024-01-09
AU2020208794A1 (en) 2021-08-05
PT3902800T (pt) 2022-11-16
EP3943493A1 (fr) 2022-01-26
CN119552163A (zh) 2025-03-04
HUE062554T2 (hu) 2023-11-28
US11590246B2 (en) 2023-02-28
KR20210109039A (ko) 2021-09-03
EP3902800B1 (fr) 2022-09-07
US20240358863A1 (en) 2024-10-31
CN113735854B (zh) 2024-05-14
KR102438394B1 (ko) 2022-09-01
HRP20230678T1 (hr) 2023-09-29
FR3091873B1 (fr) 2020-12-25
KR102502862B1 (ko) 2023-02-23
DK3943493T3 (da) 2023-07-24
DK3902800T3 (da) 2022-11-28
CL2021001868A1 (es) 2022-01-21
ES2950118T3 (es) 2023-10-05
JP2022508496A (ja) 2022-01-19
KR20210138134A (ko) 2021-11-18

Similar Documents

Publication Publication Date Title
Sato et al. A new synthesis of threonine
HRP20221291T1 (hr) Kompleks gadolinija i kelirajući ligand dobiven iz dijastereoizomerno obogaćenog pcta i postupak sinteze
CN114085244B (zh) 一种4-(羟基甲基膦酰基)-2-羰基丁酸的制备方法
JPH10218836A (ja) マロン酸およびアルキルマロン酸の製造方法
DE1958123B2 (de) Verfahren zur herstellung von 1-aminoalkan-1,1-diphosphonsaeuren oder deren salzen
CN103232369B (zh) 一种芴甲氧羰酰谷氨酸-5-叔丁酯的制备方法
HRP20151422T1 (hr) Postupak za pripremu estera (5-fluoro-2-metil-3-hinolin-2-ilmetil-indol-1-il)-octene kiseline
CN109053804B (zh) 一种替诺福韦的合成方法
SI9420074B (sl) Postopek za pripravo N-substituiranih glicinskih kislin ali glicin estrov in uporaba tega postopka za sintezo indiga
JP2627645B2 (ja) アミノフェノール類のトリグリシジル誘導体の製造法
JPH08311085A (ja) 分岐二量化アルキルリン酸塩基性アミノ酸塩の製造方法
Wiley et al. Diamides from carboxylic acids and their nitriles
US1668964A (en) Process for the manufacture of phenyl glycine or compounds thereof
CN102786547A (zh) 一种合成增甘膦的方法
CN100500645C (zh) 1-氨基环丙烷羧酸的提纯和生产方法
US1703186A (en) Cyclohexyl compound and process of making the same
US1087412A (en) Process of producing quinizarin.
DE19733243A1 (de) Verfahren zur Herstellung von 3-Cyano-2,4-dihalogen-5-fluor-benzoesäure
DE3931134C2 (de) Verfahren zur Epimerisierung einer formalen Hydroxygruppe in einem Ester
WO1995023787A1 (en) Process for producing 5,7-dichloro-4-hydroxyquinoline
US1976923A (en) Amino-alkyl-esters of the carboxy-alkoxy-amino-diphenyls
DE1695275C (de) Verfahren zur Herstellung von 3-Carbalkoxy-4-hydroxy-chinolinderivaten
JPS6126772B2 (enExample)
CN104592028A (zh) 橡胶增塑剂邻苯二甲酸二丁酯的制备方法
IE840749L (en) 6-methyl nicotinic acid esters